241 related articles for article (PubMed ID: 38772565)
21. Bacterial infections in cancer: A bilateral relationship.
Basu A; Singh R; Gupta S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1771. PubMed ID: 34994112
[TBL] [Abstract][Full Text] [Related]
22. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
Subhaswaraj P; Syed A; Siddhardha B
Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
[TBL] [Abstract][Full Text] [Related]
23. Functionalization of nanostructures for antibiotic improvement: an interdisciplinary approach.
Saúde A; Franco OL
Ther Deliv; 2016 Nov; 7(11):761-771. PubMed ID: 27790945
[TBL] [Abstract][Full Text] [Related]
24. Novel Antibacterial Strategies for Combating Bacterial Multidrug Resistance.
Xu XL; Kang XQ; Qi J; Jin FY; Liu D; Du YZ
Curr Pharm Des; 2019; 25(44):4717-4724. PubMed ID: 31642769
[TBL] [Abstract][Full Text] [Related]
25. Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment.
Zhang W; Hu E; Wang Y; Miao S; Liu Y; Hu Y; Liu J; Xu B; Chen D; Shen Y
Int J Nanomedicine; 2021; 16():6141-6156. PubMed ID: 34511911
[TBL] [Abstract][Full Text] [Related]
26. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
27. Nanomedicines for combating multidrug resistance of cancer.
Zhu YX; Jia HR; Duan QY; Wu FG
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1715. PubMed ID: 33860622
[TBL] [Abstract][Full Text] [Related]
28. The challenges and applications of nanotechnology against bacterial resistance.
Lei Z; Karim A
J Vet Pharmacol Ther; 2021 May; 44(3):281-297. PubMed ID: 33277732
[TBL] [Abstract][Full Text] [Related]
29. Nanomaterial in controlling biofilms and virulence of microbial pathogens.
Tungare K; Gupta J; Bhori M; Garse S; Kadam A; Jha P; Jobby R; Amanullah M; Vijayakumar S
Microb Pathog; 2024 Jul; 192():106722. PubMed ID: 38815775
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.
Uddin TM; Chakraborty AJ; Khusro A; Zidan BRM; Mitra S; Emran TB; Dhama K; Ripon MKH; Gajdács M; Sahibzada MUK; Hossain MJ; Koirala N
J Infect Public Health; 2021 Dec; 14(12):1750-1766. PubMed ID: 34756812
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic strategies to combat antibiotic resistance.
Brooks BD; Brooks AE
Adv Drug Deliv Rev; 2014 Nov; 78():14-27. PubMed ID: 25450262
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-based local antimicrobial drug delivery.
Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular Antibiotic Switches: A Potential Strategy for Combating Drug Resistance.
Bai H; Lv F; Liu L; Wang S
Chemistry; 2016 Aug; 22(32):11114-21. PubMed ID: 27312106
[TBL] [Abstract][Full Text] [Related]
34. Nanomedicine against biofilm infections: A roadmap of challenges and limitations.
Blanco-Cabra N; Alcàcer-Almansa J; Admella J; Arévalo-Jaimes BV; Torrents E
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(1):e1944. PubMed ID: 38403876
[TBL] [Abstract][Full Text] [Related]
35. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
[TBL] [Abstract][Full Text] [Related]
36. The role of nanotechnology in combating multi-drug resistant bacteria.
Singh R; Smitha MS; Singh SP
J Nanosci Nanotechnol; 2014 Jul; 14(7):4745-56. PubMed ID: 24757944
[TBL] [Abstract][Full Text] [Related]
37. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
[TBL] [Abstract][Full Text] [Related]
38. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
Natan M; Banin E
FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
[TBL] [Abstract][Full Text] [Related]
39. Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics.
Mubeen B; Ansar AN; Rasool R; Ullah I; Imam SS; Alshehri S; Ghoneim MM; Alzarea SI; Nadeem MS; Kazmi I
Antibiotics (Basel); 2021 Nov; 10(12):. PubMed ID: 34943685
[TBL] [Abstract][Full Text] [Related]
40. The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria.
Xiao G; Li J; Sun Z
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
